Larvol Cliniclarvol.hashnode.dev·Jul 26, 2024Belantamab Mafodotin Exhibits No Evidence Of Immune Cell ImpairmentTopic: Myeloma and other monoclonal gammopathies — Biology & translational research Background:Belantamab mafodotin (belamaf) is a B-cell maturation antigen (BCMA) targeted antibody-drug-conjugatewith mechanisms of action against multiple myeloma (MM...indiaAdd a thoughtful commentNo comments yetBe the first to start the conversation.